Methods and compositions for diagnosing carcinomas
CA 2369433 A1 · Owner: Hellstrom, Ingegerd · Inventors: Hellstrom, Ingegerd; Hellstrom, Karl Erik; Scholler, Nathalie B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble forms of mesothelin polypeptides, including mesothelin related antigen (MRA). In particular the invention provides a nucleic acid sequence encoding MRA and an MRA variant. The invention also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a mesothelin polypeptide with a molecule naturally occurring in soluble form in a sample from such a subject and by , hybridization screening using an MRA nucleotide sequence as well as other , related advantages.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.